Skip to main content

Animations

MJFF Publications

5511 - 5520 of 6403 Results
Title
Year
  • Year
  • 2022
  • 2017
  • 2019
  • 2025
  • 2023
  • 2018
  • 2024
  • 2017
  • 2024
  • 2017
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Cryo-TEM structure of β-glucocerebrosidase in complex with its transporter LIMP-2
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-58340-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Data Archive for the BRAIN Initiative (DABI)
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-01972-z
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in Vitro
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/acsomega.7b01897
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-024-03221-5
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice
    Journal Name: Neurobiology of Learning and Memory
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nlm.2017.05.001
    Citation Count: 13
  • Summary Details
    OPEN
    Title: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screens
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.isci.2024.111434
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.011
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.